Beam Therapeutics Inc.

AI Score

0

Unlock

23.11
-0.19 (-0.82%)
At close: Jan 15, 2025, 1:03 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -132.53M -289.09M -370.64M -194.59M -78.33M -116.74M -8.00M
Depreciation & Amortization 20.01M 14.15M 7.45M 4.74M 3.50M 650.00K 11.00K
Stock-Based Compensation 98.65M 84.32M 43.57M 15.38M 7.03M 7.00M 198.00K
Other Working Capital -108.88M 249.25M 110.44M 5.29M -14.80M 7.64M 14.00K
Other Non-Cash Items -18.87M -38.48M 158.86M 9.87M 2.02M 66.96M 3.85M
Deferred Income Tax n/a n/a -16.77M 63.52M 4.48M 11.75M 500.00K
Change in Working Capital -116.45M 251.63M 111.25M 5.35M -10.71M 10.07M 740.00K
Operating Cash Flow -149.19M 22.53M -66.27M -95.74M -72.00M -20.30M -2.71M
Capital Expenditures -33.73M -48.95M -46.81M -16.36M -12.52M -13.12M -346.00K
Acquisitions n/a 412.38M 620.00K 83.77M 54.14M n/a n/a
Purchase of Investments -984.34M -1.62B -777.22M -282.36M -130.21M -300.00K n/a
Sales Maturities Of Investments 1.09B 1.20B 529.27M 198.60M 76.07M n/a n/a
Other Investing Acitivies n/a -412.38M -247.95M -83.77M -54.14M -300.00K n/a
Investing Cash Flow 71.84M -461.34M -294.14M -100.12M -66.66M -13.42M -346.00K
Debt Repayment -2.25M -2.29M -2.12M 1.70M 5.71M n/a n/a
Common Stock Repurchased n/a n/a n/a n/a -25.19M n/a n/a
Dividend Paid n/a n/a n/a n/a -12.71M n/a n/a
Other Financial Acitivies 8.53M 5.62M 810.00K 1.10M 48.28M 179.73M 4.98M
Financial Cash Flow 276.45M 111.59M 756.14M 322.32M 41.28M 179.73M 4.98M
Net Cash Flow 199.09M -327.22M 395.73M 126.46M -97.38M 146.00M 1.93M
Free Cash Flow -182.93M -26.42M -113.08M -112.10M -84.52M -33.42M -3.05M